Caroline Kelly

7PUBLICATIONS

55CO-AUTHORS

Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jul 01, 2026

Protocol for Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, Including a Nested MRI Substudy (Meso-ORIGINS).

|Jan 09, 2026

Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority Trial.

Timothy Iveson, Mark P Saunders, Caroline Kelly

|Mar 14, 2024

Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies.

Enric Domingo, Caroline Kelly, Jennifer Hay

|Nov 23, 2023

Staging by Thoracoscopy in potentially radically treatable Lung Cancer associated with Minimal Pleural Effusion (STRATIFY): protocol of a prospective, multicentre, observational study.

Jenny Ferguson, Selina Tsim, Caroline Kelly

|Mar 29, 2023

CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data.

Eleni Karamouza, Rosalind M Glasspool, Caroline Kelly

|Dec 03, 2021

Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).

Catherine R Hanna, Sean M O'Cathail, Janet S Graham

Pageof 2

Frequent Collaborators

Catherine R Hanna

Sean M O'Cathail

Janet S Graham

Leslie Samuel

Lynsey Devlin

Susan Dillon

Fiona Thomson

Richard A Adams

Campbell S D Roxburgh

2 joint publications

Andrew Stanton

Frequent Collaborators

Catherine R Hanna

Sean M O'Cathail

Janet S Graham

Leslie Samuel